Companies: 10,795·Total market cap: $144.5T
Apyx Medical Corporation

Apyx Medical Corporation

APYXNASDAQHealthcare● Active
$4.77
+$0.30(+6.71%)
Market Cap$199738746
P/E Ratio
52W High$4.99
52W Low$1.59

Apyx Medical Corporation (APYX) Revenue

Annual & quarterly revenue history · segment & region breakdown

APYX · revenue · updated Jun 9, 2026

Core revenue metrics

Apyx Medical Corporation trailing twelve-month (TTM) revenue is $0.06B, an increase of 9.86% year-over-year from $0.05B in FY2025.

TTM revenue
$0.06B
4-quarter sum · USD
YoY growth
+9.86%
vs FY2025 $0.05B
Price / sales
3.57×
mktCap ÷ TTM rev
Revenue per day
$0M
Est. TTM ÷ 365
Revenue / employee
$254K
220 employees
FY2025
$0.05B
FY2024
$0.05B
5Y CAGR
+1.7%
Fiscal year end
Dec 31
Currency
USD · GAAP
Filing
10-K / 10-Q
Source: FMP · Apyx Medical Corporation SEC filings · GAAPUpdated: 2026-06-09

Revenue trend

20252006 · Annual
YoY revenue growth %
revenue trend · revenue chart · revenue by year · revenue history

Revenue history

Fiscal year endRevenueChangeGrowth
2025-12-31$0.05B+$0.00B+9.86%
2024-12-31$0.05B-$0.00B-8.11%
2023-12-31$0.05B+$0.01B+17.61%
2022-12-31$0.04B-$0.00B-8.26%
2021-12-31$0.05B+$0.02B+75.08%
2020-12-31$0.03B-$0.00B-1.86%
2019-12-31$0.03B+$0.01B+69.21%
2018-12-31$0.02B-$0.02B-57.09%
2017-12-31$0.04B+$0.00B+6.16%
2016-12-31$0.04B+$0.01B+24.08%
APYX revenue by year · APYX revenue history · APYX annual revenue data

Revenue breakdown

Segment & Geography
By business segment
Total$0.01B
$0.01B100.0%
By geography
Total$0.05B
$0.04B73.4%
$0.01B26.6%
Data from Apyx Medical Corporation annual 10-K filing · FY ending 2025-12-31
APYX revenue breakdown · APYX revenue by segment · APYX revenue by region

About Revenue & Reporting

Revenue (also called sales, net sales, or turnover) is the total income Apyx Medical Corporation receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.

Apyx Medical Corporation reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.

Data sourced from Apyx Medical Corporation's 10-K and 10-Q SEC filings via Financial Modeling Prep.

Figures tie to SEC 10-K/10-Q and FMP income-statement endpoints where noted.

Frequently asked questions

APYX revenue · 4 questions

APYX's trailing twelve-month (TTM) revenue is $0.06B. That is an increase of 9.86% year-over-year from $0.05B in FY2025.

APYX revenueAPYX annual revenuewhat is APYX revenueAPYX TTM revenue

Source: FMP · Apyx Medical Corporation SEC filings · GAAP · Apyx Medical Corporation SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026